Candriam SCA’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107M | Buy |
|
|||||
|
2025
Q1 | $84.1M | Sell |
|
|||||
|
2024
Q4 | $73.7M | Buy |
|
|||||
|
2024
Q3 | $76.5M | Buy |
|
|||||
|
2024
Q2 | $39.9M | Sell |
|
|||||
|
2024
Q1 | $44.5M | Buy |
|
|||||
|
2023
Q4 | $34.2M | Buy |
|
|||||
|
2023
Q3 | $31.6M | Sell |
|
|||||
|
2023
Q2 | $29M | Buy |
|
|||||
|
2023
Q1 | $29.3M | Sell |
|
|||||
|
2022
Q4 | $40.4M | Sell |
|
|||||
|
2022
Q3 | $43M | Sell |
|
|||||
|
2022
Q2 | $50.8M | Sell |
|
|||||
|
2022
Q1 | $58.3M | Buy |
|
|||||
|
2021
Q4 | $46.4M | Sell |
|
|||||
|
2021
Q3 | $37.8M | Sell |
|
|||||
|
2021
Q2 | $39.6M | Sell |
|
|||||
|
2021
Q1 | $54.6M | Buy |
|
|||||
|
2020
Q4 | $56.8M | Sell |
|
|||||
|
2020
Q3 | $58.3M | Buy |
|
|||||
|
2020
Q2 | $65.2M | Sell |
|
|||||
|
2020
Q1 | $64.2M | Hold |
|
|||||
|
2019
Q4 | $65.7M | Sell |
|
|||||
|
2019
Q3 | $65.4M | Buy |
|
|||||
|
2019
Q2 | $39.5M | Sell |
|
|||||
|
2019
Q1 | $45.7M | Buy |
|
|||||
|
2018
Q4 | $50.5M | Buy |
|
|||||
|
2018
Q3 | $49.2M | Buy |
|
|||||
|
2018
Q2 | $47.5M | Buy |
|
|||||
|
2018
Q1 | $31.4M | Buy |
|
|||||
|
2017
Q4 | $27.3M | Buy |
|
|||||
|
2017
Q3 | $19.3M | Sell |
|
|||||
|
2017
Q2 | $16.4M | Sell |
|
|||||
|
2017
Q1 | $29.4M | Buy |
|
|||||
|
2016
Q4 | $14.4M | Sell |
|
|||||
|
2016
Q3 | $28.7M | Buy |
|
|||||
|
2016
Q2 | $4.86M | Sell |
|
|||||
|
2016
Q1 | $39.1M | Buy |
|
|||||
|
2015
Q4 | $33M | Sell |
|
|||||
|
2015
Q3 | $30.7M | Buy |
|
|||||
|
2015
Q2 | $36M | Buy |
|
|||||
|
2015
Q1 | $27.3M | Sell |
|
|||||
|
2014
Q4 | $36.8M | Buy |
|